Login / Signup

Transcriptionally-active "defective" HIV-1 proviruses and their association with immunological non-response to antiretroviral therapy.

Francesca ScrimieriEstella BastianMindy SmithCatherine A RehmCaryn MorseJanaki KuruppuMary McLaughlinWeizhong ChangIrini SeretiJoseph A KovacsH Clifford LaneHiromi Imamichi
Published in: The Journal of infectious diseases (2024)
A subset of antiretroviral therapy-treated persons with HIV, referred to as immunological non-responders (INRs), fails to normalize CD4+ T-cell numbers. In a case-control study involving 26 INRs (CD4<250 cells/µL) and 25 immunological responders (IRs, CD4≥250 cells/µL), we evaluated the potential contribution of transcriptionally-competent "defective" HIV-1 proviruses to poor CD4+ T-cell recovery. Compared to the responders, the INRs had higher levels of cell-associated HIV-RNA (p=0.034) and higher percentages of HLA-DR+CD4+ T-cells (p<0.001). While not encoding replication-competent viruses, the RNA transcripts frequently encoded HIV-1 Gag-p17 and Nef proteins. These transcripts and/or resulting proteins may activate pathway(s) leading to the immunological non-response phenotype.
Keyphrases